FDA cracking down telehealth companies On March 2, the FDA announced it sent 30 letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites
A fully human monoclonal antibody, Cosentyx, which works by targeting and inhibiting the IL-17A cytokine, thereby suppressing the inflammatory pathway, was previously only authorized as a subcutaneous treatment in these indications
Most tirzepatide-related muscle pain resolves with hydration, proper nutrition, and time
By promoting DNA repair and reducing inflammation, NAD IV therapy can slow down the aging process and reduce the risk of age-related diseases
It's amazing how much variety they have that aligns perfectly with our dietary needs, making our GLP-1 Costco shopping list so much easier to fill
In preclinical research, particularly rodent studies, it has consistently demonstrated tissue-supportive effects